Chronic renal failure classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{{CMG}}; {{AE}} {{FT}}
{{CMG}}; {{AE}} {{FT}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].
The aim of chronic kidney disease (CKD) staging is to guide management, stratifying the risk of progression and complications of CKD. Risk stratification is used as a guide to inform appropriate treatments and the intensity for monitoring and patient education. In patients who are diagnosed with CKD, staging is done according to [[glomerular filtration rate]] (GFR) and [[albuminuria]].
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==
* The aim of chronic kidney disease (CKD) staging is to guide management, stratifying the risk of progression and complications of CKD.<ref name="pmid2948868">{{cite journal |vauthors=Tsibul'skaia MM, Andreeva AP, Levina AA, Shirinova EA, Tokarev IuN |title=[Combined sickle-cell anemia and alpha-thalassemia] |language=Russian |journal=Gematol Transfuziol |volume=31 |issue=11 |pages=3–7 |date=November 1986 |pmid=2948868 |doi= |url=}}</ref>
* [[Risk stratification tools|Risk stratification]] is used as a guide to inform appropriate treatments and the intensity for monitoring and patient education.
* In patients who are diagnosed with CKD, staging is done according to [[glomerular filtration rate]] (GFR) and [[albuminuria]].<ref name="pmid23727165">{{cite journal |vauthors=Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A |title=Evolving importance of kidney disease: from subspecialty to global health burden |journal=Lancet |volume=382 |issue=9887 |pages=158–69 |date=July 2013 |pmid=23727165 |doi=10.1016/S0140-6736(13)60439-0 |url=}}</ref>


*There is no established system for the classification of [disease name].
=== 1.Chronic kidney disease classification based upon glomerular filtration rate and albuminuria: ===
OR
{| class="wikitable"
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
|'''[[GFR]] stages'''
**[Group1]
|'''GFR'''(mL/min/1.73 m2)
**[Group2]
|Terms
**[Group3]
|-
**[Group4]
|G1
OR
|≥90
*[Disease name] may be classified into [large number > 6] subtypes based on:
|Normal or high
**[Classification method 1]
|-
**[Classification method 2]
|G2
**[Classification method 3]
|60 to 89
*[Disease name] may be classified into several subtypes based on:
|Mildly decreased
**[Classification method 1]
|-
**[Classification method 2]
|G3a
**[Classification method 3]
|45 to 59
OR
|Mildly to moderately decreased
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
|-
OR
|G3b
*If the staging system involves specific and characteristic findings and features:
|30 to 44
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
|Moderately to severely decreased
OR
|-
*The staging of [malignancy name] is based on the [staging system].
|G4
OR
|15 to 29
*There is no established system for the staging of [malignancy name].
|Severely decreased
|-
|G5
|<15
|Kidney failure (add D if treated by dialysis)
|-
|'''[[Albuminuria]] stages'''
|'''AER'''(mg/day)
|Terms
|-
|A1
|<30
|Normal to mildly increased (may be subdivided for risk prediction)
|-
|A2
|30 to 300
|Moderately increased
|-
|A3
|>300
|Severely increased (may be subdivided into nephrotic and non-nephrotic for differential diagnosis, management, and risk prediction)
|}


=== Acute and Chronic CKD: ===
*Based on the duration of symptoms, CKD may be classified as either acute or chronic.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 15:37, 26 July 2018

Chronic renal failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic renal failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic renal failure classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic renal failure classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic renal failure classification

CDC on Chronic renal failure classification

Chronic renal failure classification in the news

Blogs on Chronic renal failure classification

Directions to Hospitals Treating Chronic renal failure

Risk calculators and risk factors for Chronic renal failure classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Feham Tariq, MD [2]

Overview

The aim of chronic kidney disease (CKD) staging is to guide management, stratifying the risk of progression and complications of CKD. Risk stratification is used as a guide to inform appropriate treatments and the intensity for monitoring and patient education. In patients who are diagnosed with CKD, staging is done according to glomerular filtration rate (GFR) and albuminuria.

Classification

  • The aim of chronic kidney disease (CKD) staging is to guide management, stratifying the risk of progression and complications of CKD.[1]
  • Risk stratification is used as a guide to inform appropriate treatments and the intensity for monitoring and patient education.
  • In patients who are diagnosed with CKD, staging is done according to glomerular filtration rate (GFR) and albuminuria.[2]

1.Chronic kidney disease classification based upon glomerular filtration rate and albuminuria:

GFR stages GFR(mL/min/1.73 m2) Terms
G1 ≥90 Normal or high
G2 60 to 89 Mildly decreased
G3a 45 to 59 Mildly to moderately decreased
G3b 30 to 44 Moderately to severely decreased
G4 15 to 29 Severely decreased
G5 <15 Kidney failure (add D if treated by dialysis)
Albuminuria stages AER(mg/day) Terms
A1 <30 Normal to mildly increased (may be subdivided for risk prediction)
A2 30 to 300 Moderately increased
A3 >300 Severely increased (may be subdivided into nephrotic and non-nephrotic for differential diagnosis, management, and risk prediction)

Acute and Chronic CKD:

  • Based on the duration of symptoms, CKD may be classified as either acute or chronic.

References

  1. ↑ Tsibul'skaia MM, Andreeva AP, Levina AA, Shirinova EA, Tokarev I (November 1986). "[Combined sickle-cell anemia and alpha-thalassemia]". Gematol Transfuziol (in Russian). 31 (11): 3–7. PMID 2948868. Vancouver style error: initials (help)
  2. ↑ Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A (July 2013). "Evolving importance of kidney disease: from subspecialty to global health burden". Lancet. 382 (9887): 158–69. doi:10.1016/S0140-6736(13)60439-0. PMID 23727165.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Chronic_renal_failure_classification&oldid=1485354"